EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Estimation of the delay for resumption of breastfeeding after 131-iodine therapy by milk radioactivity measurement

Sarah Chaib iD, Solène Castellnou, Tassadit Keniza, Emeline Daru, Anthony Triplet, Juliette Abeillon, Perrine Tylski iD

European Thyroid Journal · 01.08.2026 · 15 (4)

DOI: 10.1530/etj-26-0012 ↗

Kurz gefasst

Fallbericht in der Zeitschrift European Thyroid Journal, online erschienen am 24.06.2026. Verfasst von Sarah Chaib und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hospices Civils de Lyon , Lyon, France. Hauptthemen laut MEDLINE: Breast Feeding, Iodine Radioisotopes, Milk, Human, Thyroid Cancer, Papillary. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Guidelines recommend stopping breastfeeding before radioactive iodine (131I) therapy, yet the optimal timing for safe resumption remains unclear. We report a detailed dosimetric case study of a 29-year-old woman treated with 3,700 MBq 131I for papillary thyroid carcinoma who wished to resume breastfeeding. Weekly breast milk samples were analyzed using calibrated gamma counting until radioactivity fell below a conservative safety threshold. Results showed substantial iodine excretion in milk (∼15% of administered activity) with biphasic clearance. Estimated infant radiation exposure varied dramatically depending on resumption timing, ranging from 0.62 to 688 mSv. A strict activity-based threshold suggested delaying breastfeeding for 51 days, whereas a dosimetric approach limiting infant exposure to 1 mSv supported resumption as early as 9–10 days post-therapy. These findings highlight the limitations of fixed recommendations and support an individualized, measurement-based strategy to optimize mother and child safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast FeedingIodine RadioisotopesMilk, HumanThyroid Cancer, PapillaryThyroid NeoplasmsAdultFemaleHumansCarcinoma, PapillaryTime Factors

Stichwörter der Autor:innen

131-iodinebreastfeedingnuclear medicinethyroid cancer

Substanzen

Iodine RadioisotopesIodine-131

Autor:innen und Institutionen

  • Hospices Civils de Lyon , Lyon, France.
  • Department of Biophysics, Institute of Pharmaceutical and Biological Sciences, Claude Bernard University Lyon 1 , Lyon, France.
  • Lyon Cancer Research Center, CNRS, INSERM , Lyon, France.

ORCID-Profile: Sarah Chaib, Perrine Tylski

Zitieren

APA

Chaib, S., Castellnou, S., Keniza, T., Daru, E., Triplet, A., Abeillon, J., & Tylski, P. (2026). Estimation of the delay for resumption of breastfeeding after 131-iodine therapy by milk radioactivity measurement. European Thyroid Journal, 15(4). https://doi.org/10.1530/etj-26-0012

Vancouver

Chaib S, Castellnou S, Keniza T, Daru E, Triplet A, Abeillon J, et al. Estimation of the delay for resumption of breastfeeding after 131-iodine therapy by milk radioactivity measurement. European Thyroid Journal. 2026;15(4). doi:10.1530/etj-26-0012

BibTeX
@article{Chaib2026,
  author = {Chaib, Sarah and Castellnou, Solène and Keniza, Tassadit and Daru, Emeline and Triplet, Anthony and Abeillon, Juliette and Tylski, Perrine},
  title = {Estimation of the delay for resumption of breastfeeding after 131-iodine therapy by milk radioactivity measurement},
  journal = {European Thyroid Journal},
  year = {2026},
  volume = {15},
  number = {4},
  doi = {10.1530/etj-26-0012}
}
Kostenlos starten →